Private Advisor Group LLC Decreases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Private Advisor Group LLC lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 198,822 shares of the exchange traded fund’s stock after selling 26,023 shares during the quarter. Private Advisor Group LLC owned about 0.26% of SPDR S&P Biotech ETF worth $17,906,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $141,284,000. Assetmark Inc. raised its position in SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares during the period. Mirae Asset Securities USA Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after purchasing an additional 300,000 shares during the last quarter. Finally, Sivik Global Healthcare LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $29,640,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $92.53 on Thursday. The company has a market cap of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11. The business’s 50 day moving average price is $91.42 and its 200-day moving average price is $96.00. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.